France· FR:62067536
CISATRACURIUM ACCORDPHARMA 2 mg/mL, solution injectable/pour perfusion
A cisatracurium product containing bésilate de cisatracurium, registered in France by ACCORD HEALTHCARE FRANCE. The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Cisatracurium is registered in 15 of 19 countries.
Countries holding a registration under ATC M03AC11 (cisatracurium), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Cisatracurium · ATC M03AC11
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BÉSILATE DE CISATRACURIUM
- Manufacturer
- ACCORD HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- M03AC11
- ATC class
- Cisatracurium
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009550723485 flacons en verre de 5 mL
- cip1334009550723625 flacons en verre de 10 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for cisatracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cisatracurium · interactions on record
89 records
- 12 severe
- 44 moderate
- 4 minor
- 29 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cisatracurium in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCisatracurium Accord 2 mg/ml oplossing voor injectie of infusieAccord Healthcare B.V.
- United StatesCisatracuriumFresenius Kabi USA, LLC
- BelgiumCisatracurium Accord Healthcare 2 mg/mlAccord Healthcare
- CzechiaCISATRACURIUM KABIFresenius Kabi s.r.o., Praha
- United KingdomCisatracurium besilate 10mg/5ml solution for injection ampoulesAS Kalceks
- SpainCISATRACURIO ACCORDPHARMA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- FinlandCisatracurium AccordAccord Healthcare B.V.
- PolandCisatracurium AccordAccord Healthcare Polska Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Cisatracurium Accordpharma, Cisatracurium Hikma
- Belgium · Cisatracurium Fresenius Kabi, Cisatracurium Hikma
- Cyprus · Cisatracurium Accordpharma, Cisatral
- Czechia · Cisatracurium Kabi, Cisatracurium Kalceks
- Germany · Cisatracurium Hameln, Cisatracurium Hikma
- Denmark · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- Estonia · Cisatracurium Kalceks
- Spain · Cisatracurio Accordpharma, Cisatracurio Hikma
- Finland · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- United Kingdom (Northern Ireland) · Cisatracurium, Cisatracurium Accord Healthcare
- Greece · Cisatral
- Croatia · Cisatrakurij Accordpharma
- Hungary · Cisatracurium Accordpharma, Cisatracurium Kabi
- Ireland · Cisatracurium Kalceks, Cisatracurium Noridem Enterprises
- Italy · Cisatracurio Hikma, Cisatracurio Kalceks
- Lithuania · Cisatracurium Kalceks
- Luxembourg · Nimbex
- Latvia · Cisatracurium Kalceks
- Netherlands · Cisatracurium Accord, Cisatracurium Accordpharma
- Norway · Cisatracurium Accordpharma, Cisatracurium Kalceks
- Poland · Cisatracurium Accordpharma, Cisatracurium Kabi
- Portugal · Cisatracúrio Accord, Cisatracúrio Accordpharma
- Romania · Cisatracurium Noridem
- Sweden · Cisatracurium Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df0b7f76-340b-4380-b3d3-dc05690d0dbd GET /v1/drugs/df0b7f76-340b-4380-b3d3-dc05690d0dbd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62067536",
"date_amm": "2020-04-15",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "BÉSILATE DE CISATRACURIUM",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable ou pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cisatracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.